Company Filing History:
Years Active: 2010-2018
Title: Innovations by Matthias Woellenstein in Electrotherapy
Introduction
Matthias Woellenstein is a notable inventor based in Overijse, Belgium. He has made significant contributions to the field of electrotherapy, particularly in the development of methodologies for analyzing data from implantable devices. With a total of three patents to his name, Woellenstein's work focuses on improving patient management systems through advanced signal analysis.
Latest Patents
One of Woellenstein's latest patents is a methodology for automated signal morphology analysis in implantable electrotherapy and diagnostic systems. This patent describes systems and related methods for analyzing data sensed from devices implanted in patients, such as cardiac pacing systems. The system is designed to detect and evaluate electric signals within the patient that share a common event marker. By utilizing algorithms and graphical presentations of the collected signals, deviations in signals over time can be identified and evaluated. This analysis is crucial for determining further actions related to the patient and the implanted device. Additionally, the system can be integrated with an advanced patient management system that includes a programmer or repeater capable of gathering information from the implanted device and transmitting the data to a host for evaluation at a remote location.
Career Highlights
Matthias Woellenstein is currently employed at Cardiac Pacemakers, Inc., where he continues to innovate in the field of cardiac devices. His work has been instrumental in enhancing the functionality and reliability of electrotherapy systems.
Collaborations
Some of his notable coworkers include Scott Thomas Mazar and Robert J. Sweeney. Their collaborative efforts contribute to the advancement of technologies in the medical device industry.
Conclusion
Matthias Woellenstein's contributions to the field of electrotherapy through his innovative patents and work at Cardiac Pacemakers, Inc. highlight his commitment to improving patient care. His methodologies for analyzing implantable device data are paving the way for more effective patient management systems.